Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

12.70

-0.71 (-5.29%)

At close: Mar 13, 2026, 4:00 PM EDT

12.53

-0.17 (-1.34%)

After-hours: Mar 13, 2026, 5:51 PM EDT

Enanta Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	37.44	32.3	37.23	85.39	43.99	57.21
Short-Term Investments	148.41	156.57	210.95	284.52	205.24	186.8
Cash & Short-Term Investments	185.85	188.86	248.19	369.91	249.23	244
Cash Growth	-14.23%	-23.90%	-32.91%	48.42%	2.14%	-36.89%
Accounts Receivable	8.49	6.88	6.65	8.61	20.32	23.58
Other Current Assets	4.34	8.59	44.62	44.27	42.16	51.44
Total Current Assets	198.68	204.34	299.45	422.79	311.71	319.02
Net Property, Plant & Equipment	71.31	72.94	73.35	34.71	29.75	10.65
Long-Term Investments	56.06	-	-	-	29.29	108.42
Other Long-Term Assets	3.45	3.45	3.45	4.77	4.66	0.7
Total Assets	329.5	280.73	376.25	462.28	375.41	438.79
Accounts Payable	1.89	1.95	8	4.1	6	9.54
Accrued Expenses	7.58	12.75	13.55	18.34	20.94	22.43
Current Portion of Leases	3.29	3.15	1.52	5.28	2.89	4.2
Other Current Liabilities	31.98	30.71	34.46	35.08	-	-
Total Current Liabilities	44.73	48.56	57.54	62.79	29.83	36.17
Long-Term Leases	53.78	54.76	53.94	21.24	22.37	1.13
Other Long-Term Liabilities	104.4	112.7	136.36	161.52	1.88	2.06
Total Long-Term Liabilities	158.18	167.46	190.3	182.75	24.25	3.19
Total Liabilities	202.91	216.02	247.84	245.54	54.08	39.36
Common Stock	0.29	0.21	0.21	0.21	0.21	0.2
Additional Paid-in Capital	543.5	469.77	451.34	424.69	398.03	351.03
Accumulated Other Comprehensive Income	-0.33	-0.34	0.3	-1.17	-3.72	-0.38
Retained Earnings	-416.87	-404.93	-323.04	-207	-73.18	48.58
Shareholders' Equity	126.59	64.72	128.81	216.74	321.33	399.43
Total Liabilities & Equity	329.5	280.73	376.65	462.28	375.41	438.79
Total Debt	57.07	57.9	55.47	26.51	25.26	5.33
Net Cash (Debt)	128.78	130.96	192.72	343.4	223.97	238.67
Net Cash Growth	-1.67%	-32.05%	-43.88%	53.32%	-6.16%	-36.95%
Net Cash Per Share	5.55	6.14	9.11	16.38	10.87	11.83
Book Value	126.59	64.72	128.81	216.74	321.33	399.43
Book Value Per Share	5.45	3.03	6.09	10.34	15.60	19.80
Tangible Book Value	126.59	64.72	128.81	216.74	321.33	399.43
Tangible Book Value Per Share	5.45	3.03	6.09	10.34	15.60	19.80

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q